Global Canine Influenza Vaccine Market Growth 2025-2031
The global Canine Influenza Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Canine Influenza Vaccine Industry Forecast” looks at past sales and reviews total world Canine Influenza Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Canine Influenza Vaccine sales for 2025 through 2031. With Canine Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Canine Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Canine Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Canine Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Influenza Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Influenza Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Canine Influenza Vaccine market?
What factors are driving Canine Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Canine Influenza Vaccine market opportunities vary by end market size?
How does Canine Influenza Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Canine Influenza Vaccine Industry Forecast” looks at past sales and reviews total world Canine Influenza Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Canine Influenza Vaccine sales for 2025 through 2031. With Canine Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Canine Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Canine Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Canine Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Influenza Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Influenza Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- H3N2 Vaccine
- H3N8 Vaccine
- Vaccination Clinic
- Pet Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bharat Biotech
- GSK
- Novartis
- Merck Animal Health
- Roche
- Zoetis
- CSL Limited
- CNBG
- LIAONING CHENGDA
What is the 10-year outlook for the global Canine Influenza Vaccine market?
What factors are driving Canine Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Canine Influenza Vaccine market opportunities vary by end market size?
How does Canine Influenza Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bicycle Lighting Market Size (2020-2031)
2.1.2 Bicycle Lighting Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Bicycle Lighting by Country/Region (2020, 2024 & 2031)
2.2 Bicycle Lighting Segment by Type
2.2.1 LED Lamps
2.2.2 Low-Cost Battery Lights
2.2.3 Flashlights
2.2.4 Halogen Lights
2.2.5 HID Lights
2.2.6 Filament Lamps
2.2.7 Others
2.3 Bicycle Lighting Market Size by Type
2.3.1 Bicycle Lighting Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Bicycle Lighting Market Size Market Share by Type (2020-2025)
2.4 Bicycle Lighting Segment by Application
2.4.1 Amateur Market
2.4.2 Professional Market
2.5 Bicycle Lighting Market Size by Application
2.5.1 Bicycle Lighting Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Bicycle Lighting Market Size Market Share by Application (2020-2025)
3 BICYCLE LIGHTING MARKET SIZE BY PLAYER
3.1 Bicycle Lighting Market Size Market Share by Player
3.1.1 Global Bicycle Lighting Revenue by Player (2020-2025)
3.1.2 Global Bicycle Lighting Revenue Market Share by Player (2020-2025)
3.2 Global Bicycle Lighting Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BICYCLE LIGHTING BY REGION
4.1 Bicycle Lighting Market Size by Region (2020-2025)
4.2 Global Bicycle Lighting Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bicycle Lighting Market Size Growth (2020-2025)
4.4 APAC Bicycle Lighting Market Size Growth (2020-2025)
4.5 Europe Bicycle Lighting Market Size Growth (2020-2025)
4.6 Middle East & Africa Bicycle Lighting Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Bicycle Lighting Market Size by Country (2020-2025)
5.2 Americas Bicycle Lighting Market Size by Type (2020-2025)
5.3 Americas Bicycle Lighting Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bicycle Lighting Market Size by Region (2020-2025)
6.2 APAC Bicycle Lighting Market Size by Type (2020-2025)
6.3 APAC Bicycle Lighting Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bicycle Lighting Market Size by Country (2020-2025)
7.2 Europe Bicycle Lighting Market Size by Type (2020-2025)
7.3 Europe Bicycle Lighting Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bicycle Lighting by Region (2020-2025)
8.2 Middle East & Africa Bicycle Lighting Market Size by Type (2020-2025)
8.3 Middle East & Africa Bicycle Lighting Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BICYCLE LIGHTING MARKET FORECAST
10.1 Global Bicycle Lighting Forecast by Region (2026-2031)
10.1.1 Global Bicycle Lighting Forecast by Region (2026-2031)
10.1.2 Americas Bicycle Lighting Forecast
10.1.3 APAC Bicycle Lighting Forecast
10.1.4 Europe Bicycle Lighting Forecast
10.1.5 Middle East & Africa Bicycle Lighting Forecast
10.2 Americas Bicycle Lighting Forecast by Country (2026-2031)
10.2.1 United States Market Bicycle Lighting Forecast
10.2.2 Canada Market Bicycle Lighting Forecast
10.2.3 Mexico Market Bicycle Lighting Forecast
10.2.4 Brazil Market Bicycle Lighting Forecast
10.3 APAC Bicycle Lighting Forecast by Region (2026-2031)
10.3.1 China Bicycle Lighting Market Forecast
10.3.2 Japan Market Bicycle Lighting Forecast
10.3.3 Korea Market Bicycle Lighting Forecast
10.3.4 Southeast Asia Market Bicycle Lighting Forecast
10.3.5 India Market Bicycle Lighting Forecast
10.3.6 Australia Market Bicycle Lighting Forecast
10.4 Europe Bicycle Lighting Forecast by Country (2026-2031)
10.4.1 Germany Market Bicycle Lighting Forecast
10.4.2 France Market Bicycle Lighting Forecast
10.4.3 UK Market Bicycle Lighting Forecast
10.4.4 Italy Market Bicycle Lighting Forecast
10.4.5 Russia Market Bicycle Lighting Forecast
10.5 Middle East & Africa Bicycle Lighting Forecast by Region (2026-2031)
10.5.1 Egypt Market Bicycle Lighting Forecast
10.5.2 South Africa Market Bicycle Lighting Forecast
10.5.3 Israel Market Bicycle Lighting Forecast
10.5.4 Turkey Market Bicycle Lighting Forecast
10.6 Global Bicycle Lighting Forecast by Type (2026-2031)
10.7 Global Bicycle Lighting Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Bicycle Lighting Forecast
11 KEY PLAYERS ANALYSIS
11.1 Light & motion
11.1.1 Light & motion Company Information
11.1.2 Light & motion Bicycle Lighting Product Offered
11.1.3 Light & motion Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Light & motion Main Business Overview
11.1.5 Light & motion Latest Developments
11.2 Cygolite
11.2.1 Cygolite Company Information
11.2.2 Cygolite Bicycle Lighting Product Offered
11.2.3 Cygolite Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Cygolite Main Business Overview
11.2.5 Cygolite Latest Developments
11.3 CATEYE
11.3.1 CATEYE Company Information
11.3.2 CATEYE Bicycle Lighting Product Offered
11.3.3 CATEYE Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 CATEYE Main Business Overview
11.3.5 CATEYE Latest Developments
11.4 Trelock
11.4.1 Trelock Company Information
11.4.2 Trelock Bicycle Lighting Product Offered
11.4.3 Trelock Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Trelock Main Business Overview
11.4.5 Trelock Latest Developments
11.5 Niterider
11.5.1 Niterider Company Information
11.5.2 Niterider Bicycle Lighting Product Offered
11.5.3 Niterider Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Niterider Main Business Overview
11.5.5 Niterider Latest Developments
11.6 Topeak
11.6.1 Topeak Company Information
11.6.2 Topeak Bicycle Lighting Product Offered
11.6.3 Topeak Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Topeak Main Business Overview
11.6.5 Topeak Latest Developments
11.7 Blackburn
11.7.1 Blackburn Company Information
11.7.2 Blackburn Bicycle Lighting Product Offered
11.7.3 Blackburn Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Blackburn Main Business Overview
11.7.5 Blackburn Latest Developments
11.8 Sigma
11.8.1 Sigma Company Information
11.8.2 Sigma Bicycle Lighting Product Offered
11.8.3 Sigma Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sigma Main Business Overview
11.8.5 Sigma Latest Developments
11.9 ROXIM
11.9.1 ROXIM Company Information
11.9.2 ROXIM Bicycle Lighting Product Offered
11.9.3 ROXIM Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 ROXIM Main Business Overview
11.9.5 ROXIM Latest Developments
11.10 Exposure
11.10.1 Exposure Company Information
11.10.2 Exposure Bicycle Lighting Product Offered
11.10.3 Exposure Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Exposure Main Business Overview
11.10.5 Exposure Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bicycle Lighting Market Size (2020-2031)
2.1.2 Bicycle Lighting Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Bicycle Lighting by Country/Region (2020, 2024 & 2031)
2.2 Bicycle Lighting Segment by Type
2.2.1 LED Lamps
2.2.2 Low-Cost Battery Lights
2.2.3 Flashlights
2.2.4 Halogen Lights
2.2.5 HID Lights
2.2.6 Filament Lamps
2.2.7 Others
2.3 Bicycle Lighting Market Size by Type
2.3.1 Bicycle Lighting Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Bicycle Lighting Market Size Market Share by Type (2020-2025)
2.4 Bicycle Lighting Segment by Application
2.4.1 Amateur Market
2.4.2 Professional Market
2.5 Bicycle Lighting Market Size by Application
2.5.1 Bicycle Lighting Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Bicycle Lighting Market Size Market Share by Application (2020-2025)
3 BICYCLE LIGHTING MARKET SIZE BY PLAYER
3.1 Bicycle Lighting Market Size Market Share by Player
3.1.1 Global Bicycle Lighting Revenue by Player (2020-2025)
3.1.2 Global Bicycle Lighting Revenue Market Share by Player (2020-2025)
3.2 Global Bicycle Lighting Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BICYCLE LIGHTING BY REGION
4.1 Bicycle Lighting Market Size by Region (2020-2025)
4.2 Global Bicycle Lighting Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bicycle Lighting Market Size Growth (2020-2025)
4.4 APAC Bicycle Lighting Market Size Growth (2020-2025)
4.5 Europe Bicycle Lighting Market Size Growth (2020-2025)
4.6 Middle East & Africa Bicycle Lighting Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Bicycle Lighting Market Size by Country (2020-2025)
5.2 Americas Bicycle Lighting Market Size by Type (2020-2025)
5.3 Americas Bicycle Lighting Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bicycle Lighting Market Size by Region (2020-2025)
6.2 APAC Bicycle Lighting Market Size by Type (2020-2025)
6.3 APAC Bicycle Lighting Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bicycle Lighting Market Size by Country (2020-2025)
7.2 Europe Bicycle Lighting Market Size by Type (2020-2025)
7.3 Europe Bicycle Lighting Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bicycle Lighting by Region (2020-2025)
8.2 Middle East & Africa Bicycle Lighting Market Size by Type (2020-2025)
8.3 Middle East & Africa Bicycle Lighting Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BICYCLE LIGHTING MARKET FORECAST
10.1 Global Bicycle Lighting Forecast by Region (2026-2031)
10.1.1 Global Bicycle Lighting Forecast by Region (2026-2031)
10.1.2 Americas Bicycle Lighting Forecast
10.1.3 APAC Bicycle Lighting Forecast
10.1.4 Europe Bicycle Lighting Forecast
10.1.5 Middle East & Africa Bicycle Lighting Forecast
10.2 Americas Bicycle Lighting Forecast by Country (2026-2031)
10.2.1 United States Market Bicycle Lighting Forecast
10.2.2 Canada Market Bicycle Lighting Forecast
10.2.3 Mexico Market Bicycle Lighting Forecast
10.2.4 Brazil Market Bicycle Lighting Forecast
10.3 APAC Bicycle Lighting Forecast by Region (2026-2031)
10.3.1 China Bicycle Lighting Market Forecast
10.3.2 Japan Market Bicycle Lighting Forecast
10.3.3 Korea Market Bicycle Lighting Forecast
10.3.4 Southeast Asia Market Bicycle Lighting Forecast
10.3.5 India Market Bicycle Lighting Forecast
10.3.6 Australia Market Bicycle Lighting Forecast
10.4 Europe Bicycle Lighting Forecast by Country (2026-2031)
10.4.1 Germany Market Bicycle Lighting Forecast
10.4.2 France Market Bicycle Lighting Forecast
10.4.3 UK Market Bicycle Lighting Forecast
10.4.4 Italy Market Bicycle Lighting Forecast
10.4.5 Russia Market Bicycle Lighting Forecast
10.5 Middle East & Africa Bicycle Lighting Forecast by Region (2026-2031)
10.5.1 Egypt Market Bicycle Lighting Forecast
10.5.2 South Africa Market Bicycle Lighting Forecast
10.5.3 Israel Market Bicycle Lighting Forecast
10.5.4 Turkey Market Bicycle Lighting Forecast
10.6 Global Bicycle Lighting Forecast by Type (2026-2031)
10.7 Global Bicycle Lighting Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Bicycle Lighting Forecast
11 KEY PLAYERS ANALYSIS
11.1 Light & motion
11.1.1 Light & motion Company Information
11.1.2 Light & motion Bicycle Lighting Product Offered
11.1.3 Light & motion Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Light & motion Main Business Overview
11.1.5 Light & motion Latest Developments
11.2 Cygolite
11.2.1 Cygolite Company Information
11.2.2 Cygolite Bicycle Lighting Product Offered
11.2.3 Cygolite Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Cygolite Main Business Overview
11.2.5 Cygolite Latest Developments
11.3 CATEYE
11.3.1 CATEYE Company Information
11.3.2 CATEYE Bicycle Lighting Product Offered
11.3.3 CATEYE Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 CATEYE Main Business Overview
11.3.5 CATEYE Latest Developments
11.4 Trelock
11.4.1 Trelock Company Information
11.4.2 Trelock Bicycle Lighting Product Offered
11.4.3 Trelock Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Trelock Main Business Overview
11.4.5 Trelock Latest Developments
11.5 Niterider
11.5.1 Niterider Company Information
11.5.2 Niterider Bicycle Lighting Product Offered
11.5.3 Niterider Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Niterider Main Business Overview
11.5.5 Niterider Latest Developments
11.6 Topeak
11.6.1 Topeak Company Information
11.6.2 Topeak Bicycle Lighting Product Offered
11.6.3 Topeak Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Topeak Main Business Overview
11.6.5 Topeak Latest Developments
11.7 Blackburn
11.7.1 Blackburn Company Information
11.7.2 Blackburn Bicycle Lighting Product Offered
11.7.3 Blackburn Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Blackburn Main Business Overview
11.7.5 Blackburn Latest Developments
11.8 Sigma
11.8.1 Sigma Company Information
11.8.2 Sigma Bicycle Lighting Product Offered
11.8.3 Sigma Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sigma Main Business Overview
11.8.5 Sigma Latest Developments
11.9 ROXIM
11.9.1 ROXIM Company Information
11.9.2 ROXIM Bicycle Lighting Product Offered
11.9.3 ROXIM Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 ROXIM Main Business Overview
11.9.5 ROXIM Latest Developments
11.10 Exposure
11.10.1 Exposure Company Information
11.10.2 Exposure Bicycle Lighting Product Offered
11.10.3 Exposure Bicycle Lighting Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Exposure Main Business Overview
11.10.5 Exposure Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Canine Influenza Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Canine Influenza Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of H3N2 Vaccine
Table 4. Major Players of H3N8 Vaccine
Table 5. Global Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 6. Global Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Canine Influenza Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Canine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Canine Influenza Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Canine Influenza Vaccine Sale by Application (2020-2025) & (K Doses)
Table 11. Global Canine Influenza Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Canine Influenza Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Canine Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Canine Influenza Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Canine Influenza Vaccine Sales by Company (2020-2025) & (K Doses)
Table 16. Global Canine Influenza Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Canine Influenza Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Canine Influenza Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Canine Influenza Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Canine Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Canine Influenza Vaccine Products Offered
Table 22. Canine Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Canine Influenza Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Canine Influenza Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Canine Influenza Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Canine Influenza Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Canine Influenza Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Canine Influenza Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Canine Influenza Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Canine Influenza Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Canine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Canine Influenza Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Canine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Canine Influenza Vaccine Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Canine Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Canine Influenza Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Canine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Canine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Canine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Canine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Canine Influenza Vaccine
Table 52. Key Market Challenges & Risks of Canine Influenza Vaccine
Table 53. Key Industry Trends of Canine Influenza Vaccine
Table 54. Canine Influenza Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Canine Influenza Vaccine Distributors List
Table 57. Canine Influenza Vaccine Customer List
Table 58. Global Canine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Canine Influenza Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Canine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Canine Influenza Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Canine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Canine Influenza Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Canine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Canine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Canine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Canine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Canine Influenza Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Canine Influenza Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Canine Influenza Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Canine Influenza Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bharat Biotech Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Bharat Biotech Canine Influenza Vaccine Product Portfolios and Specifications
Table 74. Bharat Biotech Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Bharat Biotech Main Business
Table 76. Bharat Biotech Latest Developments
Table 77. GSK Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Canine Influenza Vaccine Product Portfolios and Specifications
Table 79. GSK Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Novartis Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis Canine Influenza Vaccine Product Portfolios and Specifications
Table 84. Novartis Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Merck Animal Health Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Animal Health Canine Influenza Vaccine Product Portfolios and Specifications
Table 89. Merck Animal Health Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Merck Animal Health Main Business
Table 91. Merck Animal Health Latest Developments
Table 92. Roche Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Canine Influenza Vaccine Product Portfolios and Specifications
Table 94. Roche Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Zoetis Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Zoetis Canine Influenza Vaccine Product Portfolios and Specifications
Table 99. Zoetis Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Zoetis Main Business
Table 101. Zoetis Latest Developments
Table 102. CSL Limited Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Limited Canine Influenza Vaccine Product Portfolios and Specifications
Table 104. CSL Limited Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. CSL Limited Main Business
Table 106. CSL Limited Latest Developments
Table 107. CNBG Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. CNBG Canine Influenza Vaccine Product Portfolios and Specifications
Table 109. CNBG Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. CNBG Main Business
Table 111. CNBG Latest Developments
Table 112. LIAONING CHENGDA Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. LIAONING CHENGDA Canine Influenza Vaccine Product Portfolios and Specifications
Table 114. LIAONING CHENGDA Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. LIAONING CHENGDA Main Business
Table 116. LIAONING CHENGDA Latest Developments
Table 1. Canine Influenza Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Canine Influenza Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of H3N2 Vaccine
Table 4. Major Players of H3N8 Vaccine
Table 5. Global Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 6. Global Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Canine Influenza Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Canine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Canine Influenza Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Canine Influenza Vaccine Sale by Application (2020-2025) & (K Doses)
Table 11. Global Canine Influenza Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Canine Influenza Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Canine Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Canine Influenza Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Canine Influenza Vaccine Sales by Company (2020-2025) & (K Doses)
Table 16. Global Canine Influenza Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Canine Influenza Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Canine Influenza Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Canine Influenza Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Canine Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Canine Influenza Vaccine Products Offered
Table 22. Canine Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Canine Influenza Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Canine Influenza Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Canine Influenza Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Canine Influenza Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Canine Influenza Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Canine Influenza Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Canine Influenza Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Canine Influenza Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Canine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Canine Influenza Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Canine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Canine Influenza Vaccine Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Canine Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Canine Influenza Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Canine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Canine Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Canine Influenza Vaccine Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Canine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Canine Influenza Vaccine Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Canine Influenza Vaccine Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Canine Influenza Vaccine
Table 52. Key Market Challenges & Risks of Canine Influenza Vaccine
Table 53. Key Industry Trends of Canine Influenza Vaccine
Table 54. Canine Influenza Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Canine Influenza Vaccine Distributors List
Table 57. Canine Influenza Vaccine Customer List
Table 58. Global Canine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Canine Influenza Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Canine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Canine Influenza Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Canine Influenza Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Canine Influenza Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Canine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Canine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Canine Influenza Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Canine Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Canine Influenza Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Canine Influenza Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Canine Influenza Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Canine Influenza Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bharat Biotech Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Bharat Biotech Canine Influenza Vaccine Product Portfolios and Specifications
Table 74. Bharat Biotech Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Bharat Biotech Main Business
Table 76. Bharat Biotech Latest Developments
Table 77. GSK Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Canine Influenza Vaccine Product Portfolios and Specifications
Table 79. GSK Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Novartis Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis Canine Influenza Vaccine Product Portfolios and Specifications
Table 84. Novartis Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Merck Animal Health Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Animal Health Canine Influenza Vaccine Product Portfolios and Specifications
Table 89. Merck Animal Health Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Merck Animal Health Main Business
Table 91. Merck Animal Health Latest Developments
Table 92. Roche Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Canine Influenza Vaccine Product Portfolios and Specifications
Table 94. Roche Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Zoetis Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Zoetis Canine Influenza Vaccine Product Portfolios and Specifications
Table 99. Zoetis Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Zoetis Main Business
Table 101. Zoetis Latest Developments
Table 102. CSL Limited Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Limited Canine Influenza Vaccine Product Portfolios and Specifications
Table 104. CSL Limited Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. CSL Limited Main Business
Table 106. CSL Limited Latest Developments
Table 107. CNBG Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. CNBG Canine Influenza Vaccine Product Portfolios and Specifications
Table 109. CNBG Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. CNBG Main Business
Table 111. CNBG Latest Developments
Table 112. LIAONING CHENGDA Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. LIAONING CHENGDA Canine Influenza Vaccine Product Portfolios and Specifications
Table 114. LIAONING CHENGDA Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. LIAONING CHENGDA Main Business
Table 116. LIAONING CHENGDA Latest Developments
LIST OF FIGURES
Figure 1. Picture of Canine Influenza Vaccine
Figure 2. Canine Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Canine Influenza Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Canine Influenza Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Canine Influenza Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Canine Influenza Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Canine Influenza Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of H3N2 Vaccine
Figure 12. Product Picture of H3N8 Vaccine
Figure 13. Global Canine Influenza Vaccine Sales Market Share by Type in 2025
Figure 14. Global Canine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Canine Influenza Vaccine Consumed in Vaccination Clinic
Figure 16. Global Canine Influenza Vaccine Market: Vaccination Clinic (2020-2025) & (K Doses)
Figure 17. Canine Influenza Vaccine Consumed in Pet Hospital
Figure 18. Global Canine Influenza Vaccine Market: Pet Hospital (2020-2025) & (K Doses)
Figure 19. Canine Influenza Vaccine Consumed in Others
Figure 20. Global Canine Influenza Vaccine Market: Others (2020-2025) & (K Doses)
Figure 21. Global Canine Influenza Vaccine Sale Market Share by Application (2024)
Figure 22. Global Canine Influenza Vaccine Revenue Market Share by Application in 2025
Figure 23. Canine Influenza Vaccine Sales by Company in 2025 (K Doses)
Figure 24. Global Canine Influenza Vaccine Sales Market Share by Company in 2025
Figure 25. Canine Influenza Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Canine Influenza Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Canine Influenza Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Canine Influenza Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 30. Americas Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 32. APAC Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 34. Europe Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Canine Influenza Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Canine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Canine Influenza Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Canine Influenza Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Canine Influenza Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Canine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Canine Influenza Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Canine Influenza Vaccine
Figure 75. Industry Chain Structure of Canine Influenza Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Canine Influenza Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Canine Influenza Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Canine Influenza Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Canine Influenza Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Canine Influenza Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Canine Influenza Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Canine Influenza Vaccine
Figure 2. Canine Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Canine Influenza Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Canine Influenza Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Canine Influenza Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Canine Influenza Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Canine Influenza Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of H3N2 Vaccine
Figure 12. Product Picture of H3N8 Vaccine
Figure 13. Global Canine Influenza Vaccine Sales Market Share by Type in 2025
Figure 14. Global Canine Influenza Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Canine Influenza Vaccine Consumed in Vaccination Clinic
Figure 16. Global Canine Influenza Vaccine Market: Vaccination Clinic (2020-2025) & (K Doses)
Figure 17. Canine Influenza Vaccine Consumed in Pet Hospital
Figure 18. Global Canine Influenza Vaccine Market: Pet Hospital (2020-2025) & (K Doses)
Figure 19. Canine Influenza Vaccine Consumed in Others
Figure 20. Global Canine Influenza Vaccine Market: Others (2020-2025) & (K Doses)
Figure 21. Global Canine Influenza Vaccine Sale Market Share by Application (2024)
Figure 22. Global Canine Influenza Vaccine Revenue Market Share by Application in 2025
Figure 23. Canine Influenza Vaccine Sales by Company in 2025 (K Doses)
Figure 24. Global Canine Influenza Vaccine Sales Market Share by Company in 2025
Figure 25. Canine Influenza Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global Canine Influenza Vaccine Revenue Market Share by Company in 2025
Figure 27. Global Canine Influenza Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Canine Influenza Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 30. Americas Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 32. APAC Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 34. Europe Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Canine Influenza Vaccine Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Canine Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas Canine Influenza Vaccine Sales Market Share by Country in 2025
Figure 38. Americas Canine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Canine Influenza Vaccine Sales Market Share by Region in 2025
Figure 46. APAC Canine Influenza Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Canine Influenza Vaccine Sales Market Share by Country in 2025
Figure 57. Europe Canine Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Canine Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Canine Influenza Vaccine in 2025
Figure 74. Manufacturing Process Analysis of Canine Influenza Vaccine
Figure 75. Industry Chain Structure of Canine Influenza Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Canine Influenza Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global Canine Influenza Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Canine Influenza Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Canine Influenza Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Canine Influenza Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Canine Influenza Vaccine Revenue Market Share Forecast by Application (2026-2031)
